stockrow
Friday 6 November 2026
Export QUCY’s income statement to Excel — free account
Quantum Cyber N.V
QUCY Healthcare Diagnostics & Research
Quantum Cyber N.V’s revenue for fiscal 2025 (year ended December 2025) was $537,100.00, down 39.9% from fiscal 2024.
- EPS
- +96.0%
- Free cash flow
- +26.7%
Quarter to June 2026, against a year earlier
0.70
0.04
−5.41%
Follow QUCY
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 5 | 4 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
4.29 | 1.96 | 21.22 | 176.32 | 0.00 | 0.00 | — |
Altman Z-Score |
(37.02) | (13.21) | (11.04) | 3.39 | 7.75 | — | — |
Altman Z″-Score (non-manufacturers) |
(86.69) | (29.03) | (26.12) | (8.72) | (4.70) | (36.58) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(1.49) | (0.22) | (4.08) | (19.82) | (1,550.11) | (20,975.51) | — |
Beneish M-Score |
(6.10) | (4.33) | (2.30) | (5.73) | (8.07) | — | — |
P/B ratio |
5.99 | 0.00 | 5.85 | 6.63 | 784.67 | 21,588.83 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 6.63 | 784.67 | 21,588.83 | — |
EV/Sales |
5.27 | 8.60 | 20.14 | 145.92 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.24) | (0.32) | (0.82) | (5.24) | 0.00 | 0.00 | — |
EV/FCF |
(0.23) | (0.30) | (0.76) | (5.01) | 0.00 | 0.00 | — |
Quick Ratio |
0.26 | 1.02 | 0.78 | 4.06 | 6.54 | 0.24 | — |
Current Ratio |
0.50 | 1.30 | 0.97 | 4.33 | 7.11 | 0.27 | — |
Net Debt/EBITDA |
(0.01) | 0.23 | 0.04 | 0.62 | 0.86 | (1.40) | — |
Debt/Assets |
20.17% | 15.10% | 39.60% | 5.11% | 4.64% | 145.67% | 0.00% |
Debt/Equity |
1.68 | 0.34 | 1.88 | 0.07 | 0.07 | (0.36) | — |
Asset Turnover |
0.06 | 0.06 | 0.05 | 0.04 | 0.11 | 1.47 | — |
Operating CF/Net income |
0.68 | 0.80 | 0.83 | 0.56 | 0.28 | 0.80 | — |
Capex/Depreciation |
(1.68) | (0.33) | (2.19) | (1.73) | (0.24) | (0.16) | — |
Interest Coverage |
(43.21) | (19.86) | (32.91) | (126.10) | (48.82) | (3.82) | — |
| (488.32%) | (467.15%) | (303.20%) | (257.97%) | (645.93%) | 0.00% | — | |
| (172.19%) | (149.42%) | (147.52%) | (174.28%) | (218.22%) | (174.34%) | — | |
ROIC |
(1,219.26%) | (651.38%) | (730.26%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
2,142.29% | (674.23%) | (1,819.39%) | (178.32%) | (140.92%) | 120.94% | — |
Average Days of Receivables |
53.28 | 20.74 | 38.15 | 46.15 | 70.69 | 32.68 | — |
Research and Development Expense of Revenue |
923.59% | 684.14% | 1,070.95% | 947.24% | 80.84% | 63.19% | — |
Selling, General and Administrative Expense of Revenue |
1,662.26% | 1,480.08% | 1,961.36% | 4,077.52% | 1,634.42% | 98.24% | — |
Intangible Assets out of Total Assets |
0.21 | 0.22 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
498.08% | 103.33% | 447.30% | 1,853.97% | 1,113.84% | 0.00% | — |
Graham Net Nets |
(0.12) | (5.82) | (0.17) | 0.13 | 0.00 | 0.00 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(4,477.07%) | (1,543.63%) | (142.49%) | (28.24%) | (9.84%) | (9.84%) | — |
Free Cash Flow Yield |
(532.18%) | (1,444.56%) | (125.42%) | (16.51%) | 0.00% | 0.00% | — |
Revenue per Share |
0.09 | 0.91 | 2.21 | 1.50 | 3.20 | 3.52 | — |
Operating CF per Share |
(1.83) | (17.58) | (54.02) | (41.73) | (17.86) | (3.34) | — |
Capex per Share |
(0.17) | (0.23) | (4.68) | (1.86) | (0.09) | (0.07) | — |
Free Cash Flow per Share |
(2.00) | (17.82) | (58.70) | (43.59) | (17.95) | (3.41) | — |
Cash per Share |
0.15 | 6.33 | 17.41 | 48.44 | 48.41 | 0.87 | — |
Shareholders Equity per Share |
0.11 | 6.08 | 8.00 | 39.83 | 35.28 | (19.55) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.11 | 6.08 | 8.00 | 39.83 | 35.28 | (19.55) | — |
Free Cash Flow |
(12.01) | (17.56) | (23.84) | (15.43) | (3.24) | (0.48) | — |
Working Capital |
(1.85) | 1.84 | (0.26) | 14.14 | 8.26 | (0.52) | — |
Capital Expenditures |
(1.03) | (0.23) | (1.90) | (0.66) | (0.02) | (0.01) | — |
Net Current Asset Value |
(2.84) | 0.52 | (3.18) | 12.23 | 5.93 | (3.23) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
1.92 | 0.26 | 2.12 | 1.24 | 0.03 | 0.02 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.56 | 0.51 | 0.51 | 0.57 | 1.84 | 2.00 | — |
Cash ROIC |
(461.06%) | (123.04%) | (145.15%) | (47.81%) | (20.81%) | 29.20% | — |
Accounts Receivable Turnover |
8.31 | 12.38 | 11.15 | 5.93 | 7.40 | 0.00 | — |
Accounts Payable Turnover |
0.08 | 0.10 | 0.12 | 0.20 | 0.68 | 0.00 | — |
Inventory Turnover |
0.50 | 0.65 | 0.98 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
2,355.03 | 3,355.00 | 3,296.45 | 2,852.50 | 716.67 | 393.18 | — |
Days of Inventory on Hand |
537.46 | 426.54 | 580.52 | 184.23 | 0.00 | 0.00 | — |
Average Receivables |
0.06 | 0.07 | 0.08 | 0.09 | 0.08 | — | — |
Average Payables |
1.94 | 3.21 | 3.10 | 1.75 | 0.59 | — | — |
Average Inventory |
0.29 | 0.49 | 0.39 | — | — | — | — |
Average Assets |
9.41 | 14.46 | 17.83 | 15.14 | 5.36 | 0.34 | — |
Average Common Equity |
3.32 | 4.62 | 8.67 | 10.23 | 1.81 | — | — |
Columns are period end dates · fundamentals updated 25 Oct 2026